Zymeworks Set to Join Russell 3000®, Russell 2000®

VANCOUVER, British Columbia, June 26, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced that it is set to join both the Russell 3000®, Ru...

Related Keywords

Delaware , United States , Ireland , Vancouver , British Columbia , Canada , United Kingdom , British , Diana Papove , Kenneth Galbraith , Beigene Ltd , Zymeworks Inc , Jazz Pharmaceuticals Ireland , Nasdaq , Corporate Communications , Securities Exchange , Russell Microcap , Chief Executive Officer , Jazz Pharmaceuticals Ireland Limited , Securities Act , Securities Exchange Act , Russell Microcap Indexes , Zymework Quarterly Report , Although Zymeworks , Media Inquiries ,